MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcvm.2025.1419873

Медицинская библиотека · Frontiers in cardiovascular medicine · 2025

Novel device therapies in heart failure: focus on patient selection.

Balgobind Amrita, Asemota Daniel, Rodriguez Emily, Wattanachayakul Phuuwadith, Fudim Marat, Alvarez Villela Miguel

СтатьяОбзорПеревод пока не подготовлен

Аннотация

The increasing prevalence of heart failure (HF) has led to advancements in therapeutic strategies, including the development of new pharmacological treatments and the expansion of guideline recommendations across the spectrum of left ventricular ejection fractions. Despite these advancements, the full benefits of guideline-directed medical therapy (GDMT) are often limited by various barriers that result in incomplete implementation or suboptimal responses. For patients who cannot tolerate or only partially respond to GDMT, therapeutic options remain limited. This gap is particularly significant for those with contraindications to heart replacement therapies (HRT), such as left ventricular assist device (LVAD) or heart transplant. In light of these potential limitations, this review article proposes categorizing HF patients into four distinct phenoprofiles based on their tolerance to GDMT and candidacy for HRT. Considering these HF phenoprofiles may guide treatment decisions regarding the selection and use of novel device-based HF therapies. Furthermore, we summarize data on commercially available and emerging device-based HF therapies, evaluating their clinical utility, mechanisms of action, and selection criteria based on current evidence. Finally, we describe clinical cases across various proposed HF phenoprofiles to illustrate how these HF profiles can guide the use of novel device-based therapies to achieve clinical stability, improve GDMT tolerance, or serve as a bridge to, or be used in tandem with HRT in select patients.

Для цитирования: Balgobind Amrita, Asemota Daniel, Rodriguez Emily, Wattanachayakul Phuuwadith, Fudim Marat, Alvarez Villela Miguel. Novel device therapies in heart failure: focus on patient selection.. Frontiers in cardiovascular medicine. 2025. DOI: 10.3389/fcvm.2025.1419873.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.